Factors Predicting Hospital Stays of Patients with Advanced Cancer Receiving Morphine and its Derivatives

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

TCTR

Registry ID

TCTR20181120002

Enrollment

290

Registered

2018-11-20

Start date

2018-10-12

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

factors predicting hospital stays of patients with advanced cancer receiving morphine and its derivatives morphine advanced cancer hospital stays predicting factors

Interventions

Patients with advanced cancer receiving morphine and its derivatives

Supportive Care

Patients with advanced cancer

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: advanced cancer patients receiving morphine and its derivatives, prior to their mortality in the hospital

Exclusion criteria

Exclusion criteria: patients having surgery or other medical interventions

Design outcomes

Primary

Measure	Time frame
Hospital stays admission till discharge day	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Thailand

Contacts

Public ContactRuechuta Molek

Chulabhorn hospital

ruechuta.molek@gmail.com+6618661516

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026